PE20020557A1 - Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual - Google Patents

Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual

Info

Publication number
PE20020557A1
PE20020557A1 PE2001001164A PE2001001164A PE20020557A1 PE 20020557 A1 PE20020557 A1 PE 20020557A1 PE 2001001164 A PE2001001164 A PE 2001001164A PE 2001001164 A PE2001001164 A PE 2001001164A PE 20020557 A1 PE20020557 A1 PE 20020557A1
Authority
PE
Peru
Prior art keywords
sexual dysfunction
receptor agonists
dopamine
receptor
selective dopamine
Prior art date
Application number
PE2001001164A
Other languages
English (en)
Inventor
Jorge D Brioni
Teodozyj Kolasa
Gin C Hsieh
Diana L Donnelly-Roberts
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020557(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20020557A1 publication Critical patent/PE20020557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

SE REFIERE AL USO DE UN AGONISTA DEL RECEPTOR DE DOPAMINA D4 CON LA SALVEDAD QUE DICHO AGONISTA NO SEA 5,6,6a-7-TETRAHIDRO-6-METIL-4H-DIBENZO[de,g]QUINOLINA-10,11-DIOL. EL AGONISTA DEL RECEPTOR DE DOPAMINA D4 SE SELECCIONA DE N-{[4-(2-CIANOFENIL)-1-PIPERAZINIL]METIL}-3-METILBENZAMIDA, 5-FLUORO-2-{[4-(2-PIRIDINIL)-1-PIPERAZINIL]METIL}-1H-INDOL DONDE DICHO AGONISTA DE DOPAMINA ES MAS SELECTIVO POR EL RECEPTOR D4 QUE POR EL RECEPTOR D2. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA UTIL PARA EL TRATAMIENTO DE UNA DISFUNCION SEXUAL
PE2001001164A 2000-11-22 2001-11-21 Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual PE20020557A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
PE20020557A1 true PE20020557A1 (es) 2002-06-25

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001164A PE20020557A1 (es) 2000-11-22 2001-11-21 Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual

Country Status (25)

Country Link
EP (1) EP1345608B1 (es)
JP (1) JP2004534725A (es)
KR (1) KR20030051857A (es)
CN (1) CN1531434A (es)
AR (1) AR035600A1 (es)
AT (1) ATE358483T1 (es)
AU (2) AU2002226895B2 (es)
BG (1) BG107810A (es)
BR (1) BR0110450A (es)
CA (1) CA2429383A1 (es)
CZ (1) CZ20031458A3 (es)
DE (1) DE60127712T2 (es)
ES (1) ES2284727T3 (es)
HK (1) HK1059884A1 (es)
HU (1) HUP0402358A3 (es)
IL (1) IL155094A0 (es)
MX (1) MXPA03004547A (es)
NO (1) NO20032304L (es)
NZ (1) NZ525086A (es)
PE (1) PE20020557A1 (es)
PL (1) PL365890A1 (es)
SK (1) SK7242003A3 (es)
TW (1) TWI293254B (es)
UY (1) UY27031A1 (es)
WO (1) WO2002041894A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
AU2003231801A1 (en) * 2002-05-23 2003-12-12 Abbott Laboratories Acetamides and benzamides that are useful in treating sexual dysfunction
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
ATE456369T1 (de) 2006-06-30 2010-02-15 Boehringer Ingelheim Int Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
JP5793828B2 (ja) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フリバンセリンの製剤及びその製造方法
KR20090045945A (ko) 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 제어 방출 시스템 및 이의 제조방법
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
EP3581567A1 (en) * 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201105T3 (es) * 1994-08-05 2004-03-16 Pfizer Inc. Derivados del bencimidazol con actividad dopaminergica.
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
IL155094A0 (en) 2003-10-31
PL365890A1 (en) 2005-01-10
CN1531434A (zh) 2004-09-22
MXPA03004547A (es) 2004-03-26
UY27031A1 (es) 2002-07-31
DE60127712T2 (de) 2007-12-27
HUP0402358A3 (en) 2009-08-28
BG107810A (bg) 2004-02-27
WO2002041894A3 (en) 2002-10-17
TWI293254B (en) 2008-02-11
AR035600A1 (es) 2004-06-16
WO2002041894A2 (en) 2002-05-30
EP1345608A2 (en) 2003-09-24
AU2002226895B2 (en) 2006-10-12
ES2284727T3 (es) 2007-11-16
NO20032304L (no) 2003-07-15
NZ525086A (en) 2006-07-28
HUP0402358A2 (hu) 2005-03-29
AU2689502A (en) 2002-06-03
BR0110450A (pt) 2005-02-09
EP1345608B1 (en) 2007-04-04
JP2004534725A (ja) 2004-11-18
SK7242003A3 (en) 2004-01-08
CA2429383A1 (en) 2002-05-30
DE60127712D1 (de) 2007-05-16
NO20032304D0 (no) 2003-05-21
CZ20031458A3 (cs) 2004-02-18
HK1059884A1 (en) 2004-07-23
ATE358483T1 (de) 2007-04-15
KR20030051857A (ko) 2003-06-25

Similar Documents

Publication Publication Date Title
CL2004000655A1 (es) Compuestos derivados de piperidin-2-ona 1,6-disustituidos, sus sales, composicion farmaceutica, agonistas del receptor ep4; uso de los compuestos para tratar hipertension ocular, glaucoma.
ATE435206T1 (de) Heteroarylsulfonylstilbene als 5-ht2a- antagonisten
PE20020557A1 (es) Uso de agonistas selectivos del receptor de dopamina d4 para tratar la disfuncion sexual
GT200500309A (es) Derivados de sulfonilbencilimidazol
MA31084B1 (fr) Derives de piperidine agonistes de gpcr
PE20010684A1 (es) Inhibidores de la reincorporacion de norepinefrina altamente selectivos y metodos para usarlos
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
PE20010683A1 (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
MX2007005205A (es) Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma.
NZ525700A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
AR050407A1 (es) Compuestos quinolinon-carboxamida como agonistas del receptor 5-ht4. procesos de obtencion y composiciones farmaceuticas
CO5580767A2 (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
CL2008003789A1 (es) Compuestos derivados de bencimidazol sustituido por carboxilo o por hidroxilo, moduladores selectivos del receptor x de farnesoide (fxr); proceso de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la diabetes, dislipidemia, sindrome metabolico, cancer, alzheimer.
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
ATE390922T1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
PE20060097A1 (es) Piridinas 2-sustituidas y procedimientos para su obtencion
CY1110443T1 (el) Υποκατεστημενα βενζοπυρανια ως εκλεκτικοι αγωνιστες υποδοχεα-βητα οιστρογονων
GEP20074192B (en) Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction
NO994850L (no) Farmakologiske midler
PE20010642A1 (es) Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietas
AR028579A1 (es) Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica
NO20052557L (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης
UY26601A1 (es) Antagonistas de los receptores de il-8

Legal Events

Date Code Title Description
FC Refusal